Adeno-associated virus antibodies and fragments thereof

Inventors

KHAN, Sohrab • GRIFFIN, Danielle • Rodino-Klapac, Louise

Assignees

Sarepta Therapeutics Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12391745-B2

Patent

Publication Date

2025-08-19

Expiration Date


Abstract

The present disclosure relates to an isolated anti-AAV (adeno-associated virus) antibody or an antigen-binding fragment thereof capable of specifically binding an epitope of AAVrh74 capsid protein and uses thereof.

Core Innovation

The invention provides an isolated anti-AAV antibody or antigen-binding fragment thereof that specifically binds an epitope of an AAV capsid protein. The epitope comprises the amino acid sequence QGAGKDNVDYSS (SEQ ID NO: 45), and the antibody is characterized by specified heavy chain variable region amino acid sequences and light chain variable region amino acid sequences.

The invention further defines specificity to AAVrh74 and reduced cross-reactivity versus AAV8 and/or AAV9. Competitive binding is described using a reference antibody, together with defined VH and VL CDR sequences mapped to SEQ ID numbers. Antibody examples include 10D2-1, 28D8-1, 1C4F4, 6E10B5, and 7D4B9.

The invention also extends the antibodies to detection use for AAVrh74 capsid or pre-existing anti-AAV antibodies in a sample. Immunoassays described include ELISA, sandwich/competitive ELISA, and ECLIA, and detection kits and labeled antibodies are described, including radioactive, enzymatic, and fluorescent labels.

Claims Coverage

The partial content provides one explicitly independent claim and dependent claims that refine the antibody and extend to diagnostic detection. The inventive features focus on epitope specificity to SEQ ID NO:45 and defined variable-region sequence identity, with multiple alternative heavy-/light-chain pairs.

Antibody epitope specificity for QGAGKDNVDYSS (SEQ ID NO: 45)

An isolated anti-AAV antibody or antigen-binding fragment that specifically binds an epitope of an AAV capsid protein, wherein the epitope comprises the amino acid sequence QGAGKDNVDYSS (SEQ ID NO: 45).

Defined heavy- and light-chain variable-region sequence identity

An antibody or antigen-binding fragment comprising heavy chain variable region amino acid sequences and light chain variable region amino acid sequences identical to SEQ ID NO: 1 and SEQ ID NO: 2, or SEQ ID NO: 5 and SEQ ID NO: 6, or SEQ ID NO: 13 and SEQ ID NO: 14, or SEQ ID NO: 9 and SEQ ID NO: 10, or SEQ ID NO: 17 and SEQ ID NO: 18.

Across the independent claim, the inventive focus is an isolated anti-AAV antibody or antigen-binding fragment that specifically binds an AAV capsid epitope containing QGAGKDNVDYSS (SEQ ID NO:45) and that is defined by specified heavy- and light-chain variable-region sequence identities through multiple alternative SEQ ID-matched pairs.

Stated Advantages

Reduced cross-reactivity versus AAV8 and/or AAV9 is described in the partial content.

Documented Applications

Detection use for AAVrh74 capsid or detection of pre-existing anti-AAV capsid antibodies in a subject sample using immunoassays, including ELISA, sandwich/competitive ELISA, and ECLIA, is described.

Use of labeled antibodies and detection kits for immunoassay formats is described, including radioactive, enzymatic, and fluorescent labels.

Competitive binding assessment using a reference antibody is described as part of characterization.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.